In vitro and in vivo characterization of [Cu][Cu(elesclomol)] as a novel theranostic agent for hypoxic solid tumors.

Cu(II)ATSM - Collaborative Medicinal Development

elesclomol (STA-4783) - Madrigal Pharma

http://www.ncbi.nlm.nih.gov/pubmed/37382663

Kathrine Røe Redalen; Laure Marignol; Maria Aanesland Dahle; Mathilde Hirsum Lystad; Morten Karlsen; Tengzhi Liu

Jun 29, 2023